- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on de Novo Myelodysplastic Syndrome
Total 2316 results
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative DiseasesUnited States
-
CelgeneCompletedMyelodysplastic SyndromeUnited States, Australia, Canada, Czechia, France, Germany, Italy, Korea, Republic of, Mexico, Poland, Sweden, United Kingdom, Belgium, Brazil, Denmark, Finland, Greece, Israel, Netherlands, Norway, Portugal, Spain, Turkey
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedAcute Myeloid Leukemia | Myelodysplastic Syndrome | Myeloproliferative Neoplasm | Myelodysplastic/Myeloproliferative NeoplasmUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative NeoplasmsUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI); Eastern Cooperative Oncology GroupCompletedMyelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative NeoplasmsUnited States
-
National Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Myelodysplastic/Myeloproliferative NeoplasmsUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative DiseasesUnited States
-
Peter MacCallum Cancer Centre, AustraliaCelgene CorporationUnknownMyelodysplasiaAustralia
-
National Institutes of Health Clinical Center (CC)CompletedMyelodysplastic Syndrome | 5q Minus SyndromeUnited States
-
Remix TherapeuticsRecruitingAcute Myeloid Leukemia | Myelodysplastic Syndromes | Acute Myeloid Leukemia Refractory | Higher Risk Myelodysplastic SyndromesUnited States
-
Saint-Louis Hospital, Paris, FranceUniversity Hospital, Clermont-Ferrand; University Hospital, Grenoble; Hospital...Completed
-
Longbio PharmaActive, not recruitingMyelodysplastic Syndrome (MDS)China
-
Otsuka Australia Pharmaceutical Pty LtdCompletedMyelodysplastic Syndrome (MDS)Australia
-
Yale UniversityWithdrawn
-
M.D. Anderson Cancer CenterCompleted
-
M.D. Anderson Cancer CenterGlaxoSmithKline; NovartisCompleted
-
CelgeneCompletedAnemiaUnited States, Belgium, Spain, United Kingdom, Austria, Canada, Germany, Portugal, France, Australia, Israel, Japan, Italy, Czechia, Poland, Turkey
-
Assistance Publique - Hôpitaux de ParisUnknown
-
Groupe Francophone des MyelodysplasiesNovartisCompleted
-
Gruppo Italiano Malattie EMatologiche dell'AdultoTerminated
-
Kyowa Kirin Co., Ltd.CompletedMDSJapan, Korea, Republic of
-
Eric Stephen Winer, MDRecruitingAcute Myeloid Leukemia | Myelodysplastic Syndrome With Excess Blasts-2United States
-
Silence Therapeutics plcCompletedNon-transfusion-dependent Thalassemia | Low Risk Myelodysplastic Syndrome | Very-Low Risk Myelodysplastic SyndromeThailand, Israel, Jordan, United Kingdom, Germany, Italy, Malaysia
-
University of UlmSunesis PharmaceuticalsCompletedAcute Myeloid Leukemia | Myelodysplastic Syndrome With Excess Blasts-2 (MDS-EB-2)Germany
-
Schrödinger, Inc.RecruitingAcute Myeloid Leukemia | High-Risk and Very High-Risk Myelodysplastic SyndromesUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); NovartisRecruitingChronic Myelomonocytic Leukemia | Myelodysplastic Syndrome | Recurrent Chronic Myelomonocytic Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Chronic Myelomonocytic Leukemia | Refractory Myelodysplastic SyndromeUnited States
-
M.D. Anderson Cancer CenterTeva Pharmaceuticals USACompleted
-
H. Lee Moffitt Cancer Center and Research InstituteCelgeneCompleted
-
M.D. Anderson Cancer CenterMillennium Pharmaceuticals, Inc.CompletedLeukemiaUnited States
-
Sunnybrook Health Sciences CentreHealth Sciences Centre, Winnipeg, Manitoba; The Ottawa Hospital; Jewish General... and other collaboratorsUnknownMyelodysplastic Syndrome (MDS)Canada
-
M.D. Anderson Cancer CenterTerminatedLeukemiaUnited States
-
M.D. Anderson Cancer CenterCelgene CorporationTerminatedLeukemiaUnited States
-
Stichting Hemato-Oncologie voor Volwassenen NederlandDeutsch-Österreichische Studiengruppe Akute Myeloische Leukämie (AMLSG)RecruitingAcute Myeloid Leukemia | Myelodysplastic Syndrome With Excess Blasts-2Australia, Austria, Belgium, Estonia, Finland, France, Germany, Ireland, Lithuania, Luxembourg, Netherlands, Norway, Spain, Sweden, Switzerland
-
Stichting Hemato-Oncologie voor Volwassenen NederlandAstellas Pharma Global Development, Inc.; Deutsch-Österreichische Studiengruppe...Active, not recruitingAcute Myeloid Leukemia | Myelodysplastic Syndrome With Excess Blasts-2Netherlands, Belgium, Germany, Switzerland, Australia, Finland, Norway, Sweden, Austria, France, Ireland, Lithuania, Luxembourg, Spain
-
GCP-Service International West GmbHSaint-Louis Hospital, Paris, France; Groupe Francophone des Myelodysplasies; Australasian... and other collaboratorsActive, not recruitingAcute Myeloid Leukemia | Myelodysplastic SyndromesGermany, France, Australia
-
AmgenCompletedMyelodysplastic Syndromes | Thrombocytopenia | MDS
-
University of Maryland, BaltimoreNational Cancer Institute (NCI); University of Maryland Greenebaum Cancer CenterCompletedMyelodysplastic Syndromes | LeukemiaUnited States
-
AmgenCompletedMyelodysplastic Syndromes | Thrombocytopenia | MDS
-
M.D. Anderson Cancer CenterCompletedLeukemia | Myelodysplastic SyndromeUnited States
-
Mirati Therapeutics Inc.CompletedMyelodysplastic Syndromes | LeukemiaCanada, United States
-
Baylor Research InstituteGenzyme, a Sanofi CompanyCompletedLeukemia | Myelodysplastic SyndromeUnited States
-
Cooperative Study Group A for HematologyCompletedLeukemia | Myelodysplastic SyndromeKorea, Republic of
-
Dongzhimen Hospital, BeijingNot yet recruiting
-
Groupe Francophone des MyelodysplasiesNovartis; Neovii BiotechActive, not recruiting
-
Aprea TherapeuticsCompletedMDSUnited States, France
-
M.D. Anderson Cancer CenterIncyte CorporationCompletedLeukemiaUnited States
-
Acceleron Pharma Inc. (a wholly owned subsidiary...Completed
-
Rush University Medical CenterCelgene CorporationTerminated
-
M.D. Anderson Cancer CenterBristol-Myers SquibbTerminatedLeukemiaUnited States
-
M.D. Anderson Cancer CenterCTI BioPharmaTerminated